UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Overbrook Management Corp

Overbrook Management Corp lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,697 shares of the healthcare conglomerate’s stock after selling 1,916 shares during the quarter. UnitedHealth Group accounts for about 3.2% of Overbrook Management Corp’s holdings, making the stock its 13th biggest position. Overbrook Management Corp’s holdings in UnitedHealth Group were worth $13,459,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $1,914,740,000. Amundi raised its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director John H. Noseworthy bought 300 shares of the stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 2.1%

NYSE UNH opened at $308.85 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a fifty day moving average of $336.21 and a 200-day moving average of $454.51. The stock has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the firm earned $6.91 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. UnitedHealth Group’s payout ratio is presently 37.02%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on UNH. Wells Fargo & Company restated an “overweight” rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, UBS Group reduced their price objective on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.